Studies have also demonstrated a genetic association of polymorphisms in Nlrp1 gene in driving the tumorigenic process, which leads to an increase in the production of downstream mediators (i.e. CASP1 and IL-1β) in malignant melanoma [83]. The gene discussed is CASP1; the disease is melanoma.